With a value of Rs 4,326 crore, this IPO is one of the largest by a domestic pharmaceutical company since Gland Pharma's Rs 6,480 crore IPO in 2020 and the largest of 2023 thus far.
With a value of Rs 4,326 crore, this IPO is one of the largest by a domestic pharmaceutical company since Gland Pharma's Rs 6,480 crore IPO in 2020 and the largest of 2023 thus far.